Additive toxicity of β-amyloid by a novel bioactive peptide in vitro: possible implications for Alzheimer's disease.
BACKGROUND: β-amyloid is regarded as a significant factor in Alzheimer's disease: but inefficient therapies based on this rationale suggests that additional signalling molecules or intermediary mechanisms must be involved in the actual initiation of the characteristic degeneration of neurons. O...
Main Authors: | Sara Garcia-Ratés, Matthew Lewis, Rosemary Worrall, Susan Greenfield |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3563650?pdf=render |
Similar Items
-
Aluminium Binding to Modified Amyloid-β Peptides: Implications for Alzheimer’s Disease
by: Cosmin Stefan Mocanu, et al.
Published: (2020-10-01) -
Amyloid peptide toxicity in an animal model of Alzheimer disease.
by: Liza Gross
Published: (2007-11-01) -
Folding simulation of amyloid β-peptide in alzheimer's disease.
by: Koh, Jessica Li Jian.
Published: (2010) -
Characterization of a Bioactive Peptide T14 in the Human and Rodent Substantia Nigra: Implications for Neurodegenerative Disease
by: Susan Adele Greenfield, et al.
Published: (2022-10-01) -
In vitro fibrillization of Alzheimer’s amyloid-β peptide (1-42)
by: Ann Tiiman, et al.
Published: (2015-09-01)